Multiple retinal haemorrhages in diabetic retinopathy after adjunctive intravitreal bevacizumab (Avastin®) with pars plana vitrectomy

被引:19
作者
Lee, Christopher Seungkyu [1 ]
Koh, Hyoung Jun [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul 120752, South Korea
关键词
D O I
10.1111/j.1600-0420.2007.01111.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:812 / 813
页数:2
相关论文
共 5 条
[1]  
*BC CANC AG, 2006, CANC MAN GUID MAN GU
[2]   A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema [J].
Cunningham, ET Jr ;
Adamis, AP ;
Altaweel, M ;
Aiello, LP ;
Bressler, NM ;
D'Amico, DJ ;
Goldbaum, M ;
Guyer, DR ;
Katz, B ;
Patel, M ;
Schwartz, SD .
OPHTHALMOLOGY, 2005, 112 (10) :1747-1757
[3]   Molecular and biological properties of vascular endothelial growth factor [J].
Ferrara, N .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (07) :527-543
[4]  
Qaum T, 2001, INVEST OPHTH VIS SCI, V42, P2408
[5]   Metrorrhagia after intravitreal injection of bevacizumab [J].
Rodrigues, Eduardo B. ;
Shiroma, Helio ;
Meyer, Carsten H. ;
Maia, Mauricio ;
Farah, Michel E. .
ACTA OPHTHALMOLOGICA SCANDINAVICA, 2007, 85 (08) :915-916